文献速递主动脉疾病

基线血浆及腹股沟结缔组织金属蛋白酶及其抑制剂与EVAR术后晚期高压内漏的相关性:长期结果

Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results.
PubMed 文献 · J Endovasc Ther · 2019-08-29

本研究纳入72例接受Endurant支架EVAR的患者,随访平均63.1个月,13例(18.1%)出现晚期内漏。仅明胶酶谱分析的proMMP-9在內漏组更高(均差8.44,95%CI -19.653至-1.087,p=0.03),且proMMP-9与晚期內漏独立相关(OR 1.055,95%CI 1.007-1.106,p=0.025)。腹股沟筋膜组织proMMP-9显著预测晚期內漏,在疝及AAA≥60mm患者中proMMP-9和活性MMP-9与晚期內漏显著相关。

要点

  • 基线明胶酶谱proMMP-9与EVAR后晚期内漏独立相关(OR 1.055)。
  • 疝患者及AAA≥60mm患者中proMMP-9和活性MMP-9为晚期内漏强预测因子。
  • 腹股沟筋膜MMP失调可能反映AAA生物学改变,或可辅助风险分层。

核心结论

  • 腹股沟筋膜组织proMMP-9显著预测EVAR术后晚期内漏。
  • 疝患者及AAA≥60mm患者中proMMP-9和活性MMP-9与晚期内漏显著相关。

研究设计与样本

  • 前瞻性连续纳入72例(平均73.1岁,68例男性)接受Endurant支架初次EVAR的患者。
  • 采集腹股沟筋膜和血液样本,基线检测血浆MMP-2、MMP-9、TIMP-1、TIMP-2及明胶酶谱MMP-2/MMP-9活性。
  • 比较随访中出现与未出现晚期内漏患者的基线指标,并行疝与AAA直径亚组分析。

主要发现

  • 平均随访63.1个月(范围7.5-91.5),13例(18.1%)出现I型(6例Ia、5例Ib)或2例III型内漏。
  • 仅明胶酶谱分析的proMMP-9在内漏组更高(均差8.44,95%CI -19.653至-1.087,p=0.03)。
  • 基线疝患者组织TIMP-2更高(0.8±0.7 vs 0.5±0.4,p=0.018),血浆总MMP-9更低(11.9±7.8 vs 16.2±7.4,p=0.042)。
  • AAA≥60mm患者组织总MMP-9(p=0.025)、总MMP-2(p=0.049)及明胶酶谱proMMP-9(p=0.018)、总MMP-9(p=0.021)均高于50-59mm患者。

关键数值与推荐

  • 回归分析示血浆总MMP-9与疝存在相关(OR 0.899,95%CI 0.817-0.989,p=0.029)。
  • 明胶酶谱proMMP-9与晚期内漏相关(OR 1.055,95%CI 1.007-1.106,p=0.025)。
  • 疝患者中proMMP-9和活性MMP-9预测晚期内漏(p=0.012和p=0.044)。
  • AAA≥60mm患者中proMMP-9和活性MMP-9预测晚期内漏(p=0.018和p=0.041)。

临床怎么用

  • 基线明胶酶谱proMMP-9或可用于EVAR术后晚期内漏风险分层。
  • 合并腹股沟疝或AAA≥60mm者应关注MMP-9相关生物标志物并加强随访。

局限性

  • 单中心小样本(72例),事件数少(13例内漏)。
  • 仅使用Endurant支架,结果外推需谨慎。
  • 生物标志物检测方法(明胶酶谱)尚未标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To investigate whether plasma and connective tissue matrix metalloproteinases (MMP) and their inhibitors (TIMP) may predict late high-pressure endoleak after endovascular aneurysm repair (EVAR). Materials and Methods: Samples of inguinal fascia and blood were collected in 72 consecutive patients (mean age 73.1 years; 68 men) undergoing primary EVAR with the Endurant stent-graft. Baseline plasma levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 and baseline MMP-2 and MMP-9 activity estimated using gelatin zymography (GZ) were compared between patients who developed late endoleak in follow-up and those who did not. Subgroup analyses were performed between patients with (n=18) and without inguinal hernias and between patients with moderate-diameter (50-59 mm; n=45) or large-diameter (≥60 mm; n=27) abdominal aortic aneurysms (AAA) at primary EVAR. Results: The mean follow-up period was 63.1 months (range 7.5-91.5), during which time 13 (18.1%) patients developed type I (6 Ia and 5 Ib) or 2 type III endoleaks. Only GZ-analyzed proMMP-9 concentrations were higher in the endoleak group than in patients without endoleak (mean difference 8.44, 95% CI -19.653 to -1.087, p=0.03). The patients with primary inguinal hernia at presentation had significantly higher tissue TIMP-2 values (0.8±0.7 vs 0.5±0.4, p=0.018) but lower plasma total (pro- + active) MMP-9 values (11.9±7.8 vs 16.2±7.4, p=0.042) than patients without hernias at the time of EVAR. Patients with AAAs ≥60 mm had significantly higher mean tissue homogenate levels of total (pro- + active) MMP-9 (p=0.025) and total (pro- + active) MMP-2 (p=0.049) as well as higher proMMP-9 (p=0.018) and total (pro- + active) MMP-9 (p=0.021) levels based on GZ compared to patients with moderate-diameter AAAs. Regression analysis revealed a significant association between total (pro- + active) MMP-9 plasma samples and the presence of hernia (OR 0.899, 95% CI 0.817 to 0.989, p=0.029) and between GZ-analyzed proMMP-9 and late endoleak (OR 1.055, 95% CI 1.007 to 1.106, p=0.025). GZ-analyzed proMMP-9 and active MMP-9 were strong predictors of late endoleak in patients with hernia (p=0.012 and p=0.044, respectively) and in patients with AAAs ≥60 mm (p=0.018 and p=0.041 respectively). Conclusion: Inguinal fascial tissue proMMP-9 significantly predicted late endoleak. ProMMP-9 and active MMP-9 biomarkers are significantly associated with late endoleak in hernia patients and in patients with AAAs ≥60 mm. Considering the clinical association between hernia and AAA and the fact that the AAA wall connective tissue environment remains exposed to systemic circulation after EVAR, inguinal fascia extracellular matrix dysregulation and altered MMP activity may reflect similar changes in AAA biology, leading to complications such as endoleak.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Georgiadis GS, Antoniou GA, Argyriou C, et al. Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results. J Endovasc Ther. 2019. PMID: 31464166. doi:10.1177/1526602819871963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。